0930 ET - Humana tells analysts on its 1Q call that medical costs are running in line with its expectations and the impact of federal billing rule changes is also playing out as predicted. The company says it had no update on its closely-watched litigation aimed at fixing a huge expected decline in quality-related Medicare bonuses. Humana said it is still aiming to achieve a 3% margin on its core business in 2027. Humana is up 6% in early trading. (anna.mathews@wsj.com)
(END) Dow Jones Newswires
April 30, 2025 09:30 ET (13:30 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。